Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: Analysis of prognostic factors and survival outcome Academic Article uri icon

Overview

MeSH Major

  • Cystadenocarcinoma, Serous
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms
  • Salvage Therapy

abstract

  • : The current data supported the definition of localized recurrent ovarian cancer as patients with 1 or 2 radiographic recurrence sites. In this select population, a diagnosis-to-recurrence interval >or=18 months and complete secondary surgical cytoreduction, which was achievable in the majority of patients, were associated with a median postrecurrence survival of approximately 50 months.

publication date

  • February 15, 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.22447

PubMed ID

  • 17219441

Additional Document Info

start page

  • 685

end page

  • 91

volume

  • 109

number

  • 4